Two for two: Sanofi snares twin European nods for enzyme replacement therapies

 
It’s a big day for Sanofi as the pharmaceutical giant welcomes two European drug approvals, both for rare enzyme deficiencies. One regulatory nod ushers in the first treatment in Europe for a particular disease. The other covers a successor to a blockbuster Sanofi drug—though that…

Source: medcitynews.comRead more